Challenges and opportunities of human iPSC-derived NK as “Off-the-shelf” cellular therapies
Nicola Romanini, Ratchapong Netsrithong, Maria Themeli, Marcella Tazzari · 2025
Read Challenges and opportunities of human iPSC-derived NK as “Off-the-shelf” cellular therapies by Nicola Romanini, Ratchapong Netsrithong, Maria Themeli, Marcella Tazzari (2025) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-12746639.txt.
Description
Nicola Romanini, Ratchapong Netsrithong, Maria Themeli, and Marcella Tazzari reviewed stem-cell-derived natural killer cells as off-the-shelf cancer therapy in two thousand twenty-five. Natural killer cells attack cancer without prior training, and making them from induced stem cells could give a uniform, ready product. Donor cells vary too much, by contrast.
Stem-cell-derived versions can be edited to boost fitness, targeting, and killing power. Several products are already in trials for blood and solid cancers. Hurdles remain: licensing limits, production yield, unclear rules, and the safety checks that multi-step editing demands. The review maps the strongest editing strategies and the pipelines of leading companies in the field.
Catalog record
| CREATOR | Nicola Romanini, Ratchapong Netsrithong, Maria Themeli, Marcella Tazzari |
|---|---|
| YEAR | 2025 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 78 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |